Publications

  1. Pietrobono S, Anichini G, Sala C, Manetti F, Almada LL, Pepe S, Carr RM, Paradise BD, Sarkaria JN, Davila JI, Tofani L, Battisti I, Arrigoni G, Ying L, Zhang C, Li H, Meves A, Fernandez-Zapico ME, Stecca B. ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL. Nat Commun. 2020 Nov 17; 11 (1):5865
    View PubMed
  2. Kung FF, Arias-Mejias SM, Quattrocchi E, Sominidi-Damodaran S, Bridges AG, Lehman JS, Weaver AL, Meves A. PD-1, PD-L1, and BIM as Predictors of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma. J Invest Dermatol. 2020 Nov; 140 (11):2301-2304.e3 Epub 2020 Apr 08
    View PubMed
  3. Eggermont AMM, Bellomo D, Arias-Mejias SM, Quattrocchi E, Sominidi-Damodaran S, Bridges AG, Lehman JS, Hieken TJ, Jakub JW, Murphree DH, Pittelkow MR, Sluzevich JC, Cappel MA, Bagaria SP, Perniciaro C, Tjien-Fooh FJ, Rentroia-Pacheco B, Wever R, van Vliet MH, Dwarkasing J, Meves A. Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model. Eur J Cancer. 2020 Nov; 140:11-18 Epub 2020 Oct 05
    View PubMed
  4. Meves A, Eggermont AMM. Deselecting Melanoma Patients for Sentinel Lymph Node Biopsy During COVID-19: Clinical Utility of Tumor Molecular Profiling. Mayo Clin Proc Innov Qual Outcomes. 2020 Oct; 4 (5):586-587 Epub 2020 July 17
    View PubMed
  5. Samarelli AV, Ziegler T, Meves A, Fassler R, Bottcher RT. Rabgap1 promotes recycling of active beta1 integrins to support effective cell migration. J Cell Sci. 2020 Sep 23; 133 (18) Epub 2020 Sept 23
    View PubMed
  6. Ekstein SF, Wyles SP, Moran SL, Meves A. Keloids: a review of therapeutic management. Int J Dermatol. 2020 Sep 9 Epub 2020 Sept 09
    View PubMed
  7. Quattrocchi E, Sominidi-Damodaran S, Murphree DH, Meves A. beta3 integrin immunohistochemistry as a method to predict sentinel lymph node status in patients with primary cutaneous melanoma. Int J Dermatol. 2020 Aug 9 Epub 2020 Aug 09
    View PubMed
  8. Arias-Mejias SM, Quattrocchi E, Tempel D, Luna-Vargas M, Chen J, Murphree DH, Gjorgova Gjeorgjievski S, Lehman JS, Bridges AG, Dwarkasing J, Meves A. Primary cutaneous melanoma risk stratification using a clinicopathologic and gene expression model: a pilot study. Int J Dermatol 2020 Jun 9 Epub 2020 June 09
    View PubMed
  9. Murphree DH, Puri P, Shamim H, Bezalel SA, Drage LA, Wang M, Pittelkow MR, Carter RE, Davis MDP, Bridges AG, Mangold AR, Yiannias JA, Tollefson MM, Lehman JS, Meves A, Otley CC, Sokumbi O, Hall MR, Comfere N. Deep Learning for Dermatologists: Part I Fundamental Concepts. J Am Acad Dermatol. 2020 May 17 [Epub ahead of print]
    View PubMed
  10. Puri P, Comfere N, Drage LA, Shamim H, Bezalel SA, Pittelkow MR, Davis MDP, Wang M, Mangold AR, Tollefson MM, Lehman JS, Meves A, Yiannias JA, Otley CC, Carter RE, Sokumbi O, Hall MR, Bridges AG, Murphree DH. Deep learning for dermatologists: Part II. Current applications. J Am Acad Dermatol. 2020 May 16 [Epub ahead of print]
    View PubMed
  11. Arias-Mejias SM, Warda KY, Quattrocchi E, Alonso-Quinones H, Sominidi-Damodaran S, Meves A. The role of integrins in melanoma: a review. Int J Dermatol. 2020 May; 59 (5):525-534 Epub 2020 Mar 10
    View PubMed
  12. Bellomo D, Arias-Mejias SM, Ramana C, Heim JB, Quattrocchi E, Sominidi-Damodaran S, Bridges AG, Lehman JS, Hieken TJ, Jakub JW, Pittelkow MR, DiCaudo DJ, Pockaj BA, Sluzevich JC, Cappel MA, Bagaria SP, Perniciaro C, Tjien-Fooh FJ, van Vliet MH, Dwarkasing J, Meves A. Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma. JCO Precis Oncol. 2020; 4:319-334 Epub 2020 Apr 14
    View PubMed
  13. Bellomo D, Bridges AG, Hieken TJ, Meves A. Reply to E. K. Bartlett et al and A. H. R. Varey et al. JCO Precis Oncol. 2020; 4:992-994 Epub 2020 Sept 03
    View PubMed
  14. Victorelli S, Lagnado A, Halim J, Moore W, Talbot D, Barrett K, Chapman J, Birch J, Ogrodnik M, Meves A, Pawlikowski JS, Jurk D, Adams PD, van Heemst D, Beekman M, Slagboom PE, Gunn DA, Passos JF. Senescent human melanocytes drive skin ageing via paracrine telomere dysfunction. EMBO J. 2019 Dec 2; 38 (23):e101982 Epub 2019 Oct 21
    View PubMed
  15. Lehman JS, Dasari S, Damodaran SS, El-Azhary RA, Gibson LE, Hashmi SK, Hogan WJ, Kenderian SJ, Patnaik MS, Litzow MR, Lazarus HM, Meves A. Differential expression of interferon-induced genes and other tissue-based biomarkers in acute graft-versus-host disease vs. lupus erythematosus in skin. Clin Exp Dermatol. 2019 Jun; 44 (4):e81-e88 Epub 2018 Oct 02
    View PubMed
  16. Kim GY, Schmelkin LA, Davis MD, El-Azhary RA, Wieland CN, Leise MD, Meves A, Lehman JS. Clinical and histopathologic manifestations of solid organ transplantation-associated graft-versus-host disease involving the skin: A single-center retrospective study. J Cutan Pathol. 2018 Nov; 45 (11):817-823 Epub 2018 Aug 19
    View PubMed
  17. Kim GY, Schmelkin LA, Davis MDP, El-Azhary RA, Farrell AM, Meves A, Lehman JS. Dermatologic manifestations of solid organ transplantation-associated graft-versus-host disease: A systematic review. J Am Acad Dermatol. 2018 Jun; 78 (6):1097-1101.e1 Epub 2017 Dec 27
    View PubMed
  18. Heim JB, McDonald CA, Wyles SP, Sominidi-Damodaran S, Squirewell EJ, Li M, Motsonelidze C, Bottcher RT, van Deursen J, Meves A. FAK auto-phosphorylation site tyrosine 397 is required for development but dispensable for normal skin homeostasis. PLoS One. 2018; 13 (7):e0200558 Epub 2018 July 12
    View PubMed
  19. Lehman JS, Hashmi SK, Lazarus HM, El-Azhary RA, Gibson LE, Hogan WJ, Litzow MR, Patnaik MS, Buadi F, Lacy MQ, Dasari S, Vanderboom P, Meves A. Immunophenotypic and molecular comparison between allogeneic and autologous graft-vs-host disease of the skin: A retrospective study using immunohistochemical and proteomics methods. J Cutan Pathol. 2017 Dec; 44 (12):1087-1091 Epub 2017 Sept 14
    View PubMed
  20. Zhu S, Zhang X, Weichert-Leahey N, Dong Z, Zhang C, Lopez G, Tao T, He S, Wood AC, Oldridge D, Ung CY, van Ree JH, Khan A, Salazar BM, Lummertz da Rocha E, Zimmerman MW, Guo F, Cao H, Hou X, Weroha SJ, Perez-Atayde AR, Neuberg DS, Meves A, McNiven MA, van Deursen JM, Li H, Maris JM, Look AT. LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis. Cancer Cell. 2017 Sep 11; 32 (3):310-323.e5 Epub 2017 Aug 31
    View PubMed
  21. Sominidi-Damodaran S, Guo R, Meves A, Bridges AG. Expanded traditional melanoma FISH testing versus CAP-QPCR to identify high-risk melanocytic lesions. Int J Dermatol 2017 Sep; 56 (9):e182-e184 Epub 2017 Mar 20
    View PubMed
  22. Laniosz V, Onajin O, Sominidi-Damodaran S, Meves A, Gibson LE, Baum CL. Natural killer cell response is a predictor of good outcome in MCPyV+ Merkel cell carcinoma: A case series of 23 patients. J Am Acad Dermatol 2017 Jul; 77 (1):31-32 Epub 2017 Mar 25
    View PubMed
  23. Heim JB, Squirewell EJ, Neu A, Zocher G, Sominidi-Damodaran S, Wyles SP, Nikolova E, Behrendt N, Saunte DM, Lock-Andersen J, Gaonkar KS, Yan H, Sarkaria JN, Krendel M, van Deursen J, Sprangers R, Stehle T, Bottcher RT, Lee JH, Ordog T, Meves A. Myosin-1E interacts with FAK proline-rich region 1 to induce fibronectin-type matrix. Proc Natl Acad Sci U S A. 2017 Apr 11; 114 (15):3933-3938 Epub 2017 Mar 27
    View PubMed
  24. Zhang X, Dong Z, Zhang C, Ung CY, He S, Tao T, Oliveira AM, Meves A, Ji B, Look AT, Li H, Neel BG, Zhu S. Critical Role for GAB2 in Neuroblastoma Pathogenesis through the Promotion of SHP2/MYCN Cooperation. Cell Rep. 2017 Mar 21; 18 (12):2932-2942
    View PubMed
  25. Sominidi-Damodaran S, Meves A. Cell adhesion phenotyping by quantitative polymerase chain reaction in melanoma: Clarifying misconceptions. J Am Acad Dermatol 2017 Jan; 76 (1):e23
    View PubMed
  26. Barrick BJ, Ida CM, Laniosz V, Jentoft ME, Sominidi-Damodaran S, Wieland CN, Meves A, Lehman JS. Bullous Pemphigoid, Neurodegenerative Disease, and Hippocampal BP180 Expression: A Retrospective Postmortem Neuropathologic Study. J Invest Dermatol 2016 Oct; 136 (10):2090-2092 Epub 2016 June 24
    View PubMed
  27. Sominidi-Damodaran S, Pittelkow MR, Meves A. Gene Expression Profiling in Cutaneous Melanoma: Caveats for Clinicians. Mayo Clin Proc 2016 Aug; 91 (8):1147-8
    View PubMed
  28. Graham RP, Terracciano LM, Meves A, Vanderboom PM, Dasari S, Yeh MM, Torbenson MS, Cruise MW. Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss. Mod Pathol. 2016 Jun; 29 (6):607-15 Epub 2016 Mar 25
    View PubMed
  29. Meves A, Nikolova E, Heim JB, Squirewell EJ, Cappel MA, Pittelkow MR, Otley CC, Behrendt N, Saunte DM, Lock-Andersen J, Schenck LA, Weaver AL, Suman VJ. Tumor Cell Adhesion As a Risk Factor for Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma. J Clin Oncol. 2015 Aug 10; 33 (23):2509-15 Epub 2015 July 06
    View PubMed
  30. Tseng HY, Thorausch N, Ziegler T, Meves A, Fassler R, Bottcher RT. Sorting nexin 31 binds multiple beta integrin cytoplasmic domains and regulates beta1 integrin surface levels and stability. J Mol Biol. 2014 Sep 9; 426 (18):3180-3194 Epub 2014 July 11
    View PubMed
  31. Meves A, Stremmel C, Bottcher RT, Fassler R. beta1 integrins with individually disrupted cytoplasmic NPxY motifs are embryonic lethal but partially active in the epidermis. J Invest Dermatol. 2013 Dec; 133 (12):2722-2731 Epub 2013 May 23
    View PubMed
  32. Zanivan S, Meves A, Behrendt K, Schoof EM, Neilson LJ, Cox J, Tang HR, Kalna G, van Ree JH, van Deursen JM, Trempus CS, Machesky LM, Linding R, Wickstrom SA, Fassler R, Mann M. In vivo SILAC-based proteomics reveals phosphoproteome changes during mouse skin carcinogenesis. Cell Rep. 2013 Feb 21; 3(2):552-66. Epub 2013 Jan 31.
    View PubMed
  33. Mathew S, Lu Z, Palamuttam RJ, Mernaugh G, Hadziselimovic A, Chen J, Bulus N, Gewin LS, Voehler M, Meves A, Ballestrem C, Fassler R, Pozzi A, Sanders CR, Zent R. beta1 integrin NPXY motifs regulate kidney collecting-duct development and maintenance by induced-fit interactions with cytosolic proteins. Mol Cell Biol. 2012 Oct; 32(20):4080-91. Epub 2012 Aug 06.
    View PubMed
  34. Bottcher RT, Stremmel C, Meves A, Meyer H, Widmaier M, Tseng HY, Fassler R. Sorting nexin 17 prevents lysosomal degradation of beta1 integrins by binding to the beta1-integrin tail. Nat Cell Biol. 2012 Jun; 14(6):584-92. Epub 2012 May 06.
    View PubMed
  35. Meves A, Geiger T, Zanivan S, DiGiovanni J, Mann M, Fassler R. Beta1 integrin cytoplasmic tyrosines promote skin tumorigenesis independent of their phosphorylation. Proc Natl Acad Sci U S A. 2011 Sep 13; 108(37):15213-8. Epub 2011 Aug 29.
    View PubMed
  36. Meves A, Stremmel C, Gottschalk K, Fassler R. The Kindlin protein family: new members to the club of focal adhesion proteins. Trends Cell Biol. 2009 Oct; 19(10):504-13. Epub 2009 Sep 18.
    View PubMed
  37. Albrecht J, Meves A, Bigby M. A survey of case reports and case series of therapeutic interventions in the Archives of Dermatology. Int J Dermatol. 2009 Jun; 48(6):592-7.
    View PubMed
  38. Brewer JD, Meves A, Bostwick JM, Hamacher KL, Pittelkow MR. Cocaine abuse: dermatologic manifestations and therapeutic approaches. J Am Acad Dermatol. 2008 Sep; 59(3):483-7. Epub 2008 May 07.
    View PubMed
  39. Brewer JD, Hundley MD, Meves A, Hargreaves J, McEvoy MT, Pittelkow MR. Staphylococcal scalded skin syndrome and toxic shock syndrome after tooth extraction. J Am Acad Dermatol. 2008 Aug; 59(2):342-6. Epub 2008 May 15.
    View PubMed
  40. Meves A, el-Azhary RA, Talwalkar JA, Moore SB, Brewer JD, Motsonelidze C, McNallan KT, Reed AM, Rosen CB. Acute graft-versus-host disease after liver transplantation diagnosed by fluorescent in situ hybridization testing of skin biopsy specimens. J Am Acad Dermatol. 2006 Oct; 55(4):642-6.
    View PubMed
  41. Meves A, Repacholi MH. Does ultraviolet radiation affect vaccination efficacy? Int J Dermatol. 2006 Sep; 45(9):1019-24.
    View PubMed
  42. Albrecht J, Meves A, Bigby M. Case reports and case series from Lancet had significant impact on medical literature. J Clin Epidemiol. 2005 Dec; 58(12):1227-32. Epub 2005 Sep 12.
    View PubMed
  43. Peus D, Beyerle A, Vasa M, Pott M, Meves A, Pittelkow MR. Antipsoriatic drug anthralin induces EGF receptor phosphorylation in keratinocytes: requirement for H(2)O(2) generation. Exp Dermatol. 2004 Feb; 13 (2):78-85
    View PubMed
  44. Meves A, Repacholi MH, Rehfuess EA. Promoting safe and effective sun protection strategies. J Am Acad Dermatol 2003 Dec; 49 (6):1203-4
    View PubMed
  45. Meves A, Repacholi MH, Rehfuess EA. Global Solar UV Index: a physician's tool for fighting the skin cancer epidemic. Int J Dermatol. 2003 Oct; 42(10):846-9.
    View PubMed
  46. Meves A, Stock SN, Beyerle A, Pittelkow MR, Peus D. Vitamin C derivative ascorbyl palmitate promotes ultraviolet-B-induced lipid peroxidation and cytotoxicity in keratinocytes. J Invest Dermatol. 2002 Nov; 119 (5):1103-8
    View PubMed
  47. Meves A, Peus D, Pittelkow MR. Okadaic acid-induced EGF receptor and MAP kinase activation does not require reactive oxygen species in primary keratinocytes. Arch Dermatol Res. 2002 Jul; 294 (5):243-5 Epub 2002 June 13
    View PubMed
  48. Meves A, Stock SN, Beyerle A, Pittelkow MR, Peus D. H(2)O(2) mediates oxidative stress-induced epidermal growth factor receptor phosphorylation. Toxicol Lett. 2001 Jul 6; 122 (3):205-14
    View PubMed
  49. Peus D, Meves A, Pott M, Beyerle A, Pittelkow MR. Vitamin E analog modulates UVB-induced signaling pathway activation and enhances cell survival. Free Radic Biol Med. 2001 Feb 15; 30 (4):425-32
    View PubMed
  50. Peus D, Vasa RA, Meves A, Beyerle A, Pittelkow MR. UVB-induced epidermal growth factor receptor phosphorylation is critical for downstream signaling and keratinocyte survival. Photochem Photobiol. 2000 Jul; 72 (1):135-40
    View PubMed
  51. Peus D, Beyerle A, Rittner HL, Pott M, Meves A, Weyand C, Pittelkow MR. Anti-psoriatic drug anthralin activates JNK via lipid peroxidation: mononuclear cells are more sensitive than keratinocytes. J Invest Dermatol. 2000 Apr; 114 (4):688-92
    View PubMed
  52. Peus D, Meves A, Vasa RA, Beyerle A, O'Brien T, Pittelkow MR. H2O2 is required for UVB-induced EGF receptor and downstream signaling pathway activation. Free Radic Biol Med. 1999 Dec; 27 (11-12):1197-202
    View PubMed
  53. Peus D, Vasa RA, Beyerle A, Meves A, Krautmacher C, Pittelkow MR. UVB activates ERK1/2 and p38 signaling pathways via reactive oxygen species in cultured keratinocytes. J Invest Dermatol. 1999 May; 112 (5):751-6
    View PubMed
  54. Peus D, Vasa RA, Meves A, Pott M, Beyerle A, Squillace K, Pittelkow MR. H2O2 is an important mediator of UVB-induced EGF-receptor phosphorylation in cultured keratinocytes. J Invest Dermatol. 1998 Jun; 110 (6):966-71
    View PubMed